Zadikoff, C., Poewe, W., Boyd, J. T., Bergmann, L., Ijacu, H., Kukreja, P., . . . Antonini, A. Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa. Wiley.
Chicago Style (17th ed.) CitationZadikoff, Cindy, Werner Poewe, James T. Boyd, Lars Bergmann, Horia Ijacu, Pavnit Kukreja, Weining Z. Robieson, Janet Benesh, and Angelo Antonini. Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa. Wiley.
MLA (9th ed.) CitationZadikoff, Cindy, et al. Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa. Wiley.
Warning: These citations may not always be 100% accurate.